The use of rocuronium in a patient with cystic fibrosis and end-stage lung disease made safe by sugammadex reversal

Anaesthesia and Intensive Care

Volumn 39, Issue 2, 2011, Pages 299-302

  Porter, M V ^a   Paleologos, M S ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Anaesthesia; Bronchiectasis; Cystic fibrosis; Neuromuscular block; Sugammadex

Indexed keywords

ADRENALIN; ALFENTANIL; BUPIVACAINE; MIDAZOLAM; PARACETAMOL; PROPOFOL; ROCURONIUM; SEVOFLURANE; SUGAMMADEX; SUXAMETHONIUM;

ADULT; ANESTHESIA INDUCTION; ARTICLE; BODY MASS; BODY WEIGHT; BRONCHIECTASIS; CASE REPORT; CLINICAL ASSESSMENT; COUGHING; CYSTIC FIBROSIS; DISEASE EXACERBATION; DRUG SAFETY; ECHOCARDIOGRAPHY; ENDOTRACHEAL INTUBATION; ENTERIC FEEDING; FEMALE; GENERAL ANESTHESIA; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; LOCAL ANESTHESIA; LUNG ARTERY PRESSURE; LUNG BAROTRAUMA; LUNG TRANSPLANTATION; MUSCLE RELAXATION; NEBULIZER; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR FUNCTION; NUTRITIONAL STATUS; OXYGEN SATURATION; OXYGEN THERAPY; PATIENT MONITORING; PATIENT PREFERENCE; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PHYSIOTHERAPY; POSTANESTHESIA CARE; POSTOPERATIVE CARE; PRESSURE SUPPORT VENTILATION; PULMONARY ASPIRATION; SEDATION; SPUTUM; TREATMENT RESPONSE;

EID: 79953185429     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1103900223     Document Type: Article

References (17)

1. Viby-Mogensen J. Postoperative residual curarization and evidence-based anaesthesia. Br J Anaesth 2000; 84:301-303. (Pubitemid 30114121)
2. Berg H, Roed J, Viby-Mogensen J, Mortensen CR, Engbaek J, Skovgaard LT et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997; 41:1095-1103. (Pubitemid 27454134)
3. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008; 107:130-137.
4. Butterly A, Bittner EA, George E, Sandberg WS, Eikermann M, Schmidt U. Postoperative residual curarization from intermediate- acting neuromuscular blocking agents delays recovery room discharge. Br J Anaesth 2010; 105:304-309.
5. Donati F. Neuromuscular monitoring: what evidence do we need to be convinced? Anesth Analg 2010; 111:6-8.
6. Ploeger BA, Smeets J, Strougo A, Drenth H-J, Ruigt G, Houwing N et al. Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex. Anesthesiology 2009; 110:95-105.
7. Fields AM, Vadivelu N. Sugammadex: a novel neuromuscular blocker binding agent. Curr Opin Anaesthesiol 2007; 20:307-310. (Pubitemid 47051889)
8. Shields M, Giovannelli M, Mirakhur RK, Moppett I, Adams J, Hermens Y. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. Br J Anaesth 2006; 96:36-43. (Pubitemid 43124528)
9. Hunter JM, Flockton EA. The doughnut and the hole: a new pharmacological concept for anaesthetists. Br J Anaesth 2006; 97:123-126. (Pubitemid 44295693)
10. Boucher RC. Cystic fibrosis. In: Harrisons Online. McGraw-Hill. From http://proxy14.use.hcn.com.au/content.aspx?aID=2866290 Accessed September 2010.
11. Huffmyer JL, Littlewood KE, Nemergut EC. Perioperative management of the adult with cystic fibrosis. Anesth Analg 2009; 109:1949-1961.
12. Caldwell JE, Miller RD. Clinical implications of sugammadex. Anaesthesia 2009; 64:66-72.
13. Staals LM, Snoeck MM, Driessen JJ, Flockton EA, Heeringa M, Hunter JM. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function. Br J Anaesth 2008; 101:492-497.
14. Unterbuchner C, Fink H, Blobner M. The use of sugammadex in a patient with myasthenia gravis. Anaesthesia 2010; 65:302-305.
15. de Boer HD, van Egmond J, Driessen JJ, Booij LHJD. Sugammadex in patients with myasthenia gravis. Anaesthesia 2010; 65:653.
16. de Boer HD, van Esmond J, Booij LH, Driessen JJ. Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy. Paediatr Anaesth 2009; 19:1226-1228.
17. Baumgartner P. Rocuronium and sugammadex in myotonic dystrophy. Anaesth Intensive Care 2010; 38:959-960.